Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor

Cristina Zanchi; Monica Locatelli; Ariela Benigni; Daniela Corna; Susanna Tomasoni; Daniela Rottoli; Flavio Gaspari; Giuseppe Remuzzi; Carlamaria Zoja

doi:10.1371/journal.pone.0070775

Loading metrics

Open Access

Peer-reviewed

Research Article

Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor

Cristina Zanchi ,

Contributed equally to this work with: Cristina Zanchi, Monica Locatelli

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Monica Locatelli ,

Contributed equally to this work with: Cristina Zanchi, Monica Locatelli

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Ariela Benigni,

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Daniela Corna,

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Susanna Tomasoni,

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Daniela Rottoli,

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯
Flavio Gaspari,

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy
⨯
Giuseppe Remuzzi,

Affiliations IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy, Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⨯
Carlamaria Zoja

* E-mail: carlamaria.zoja@marionegri.it

Affiliation IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy
⨯

Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor

Cristina Zanchi,
Monica Locatelli,
Ariela Benigni,
Daniela Corna,
Susanna Tomasoni,
Daniela Rottoli,
Flavio Gaspari,
Giuseppe Remuzzi,
Carlamaria Zoja

Published: August 14, 2013
https://doi.org/10.1371/journal.pone.0070775

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Kidneys
Is the Subject Area "Kidneys" applicable to this article?

Thanks for your feedback.
Fibroblast growth factor
Is the Subject Area "Fibroblast growth factor" applicable to this article?

Thanks for your feedback.
Phosphates
Is the Subject Area "Phosphates" applicable to this article?

Thanks for your feedback.
ACE inhibitor therapy
Is the Subject Area "ACE inhibitor therapy" applicable to this article?

Thanks for your feedback.
Excretion
Is the Subject Area "Excretion" applicable to this article?

Thanks for your feedback.
Proteinuria
Is the Subject Area "Proteinuria" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
ACE inhibitors
Is the Subject Area "ACE inhibitors" applicable to this article?

Thanks for your feedback.